Stephen L. Newman
Private Equity Investor bei JDRF T1D Fund
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Aaron J. Kowalski | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 20 Jahre |
Sean N. Doherty | M | 55 |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 9 Jahre |
Gerald L. Wisler | M | 67 |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY.
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 8 Jahre |
Meredith Schaum | F | - |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 Jahre |
Clark Tim | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 17 Jahre |
Mathieu Chantal | F | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Langer Robert | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Evans-Molina Carmella | F | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Dayan Colin | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Buckingham Bruce | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Sherr Jennifer | F | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Francine Kaufman | M | 73 |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Douglas A. Melton | M | 70 |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Jay L. Eastman | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Robert Perez | M | 59 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 Jahre |
James L. Bicksler | M | 86 |
Rutgers State University of New Jersey
| 55 Jahre |
Brady Bohrmann | M | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 9 Jahre |
Paul B. Queally | M | 59 |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Karen Jordan | F | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Thomas DesRosier | M | 69 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 Jahre |
Agiostratidou Gina | F | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | - |
Katie Ellias | F | 45 |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 6 Jahre |
Steven St. Peter | M | 57 |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 5 Jahre |
Marvin R. Haselhorst | M | - | 10 Jahre | |
R. Ramsey | M | 54 | 19 Jahre | |
Adrienne Slack | F | - |
Federal Reserve Bank of Atlanta
| 12 Jahre |
Michael Tomsicek | M | 58 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 11 Jahre |
John Kolb | M | - |
Federal Reserve Bank of Atlanta
| 12 Jahre |
Michael Chriszt | M | - |
Federal Reserve Bank of Atlanta
| 12 Jahre |
Brian Bowling | M | - |
Federal Reserve Bank of Atlanta
| 12 Jahre |
Grant Beard | M | 63 |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 8 Jahre |
Ellen Leake | F | - |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | 4 Jahre |
Jackie Lee | F | - |
Federal Reserve Bank of Atlanta
| 14 Jahre |
Joan Buchanan | F | - |
Federal Reserve Bank of Atlanta
| 14 Jahre |
N. Knight Worley | M | - |
Touro Infirmary
Touro Infirmary Hospital/Nursing ManagementHealth Services Touro Infirmary, Inc. offers healthcare services It offers acute case management, ambulatory treatment, cardiology, diabetes, emergency, family birthing center and women's health, imaging, oncology, orthopedics, physical therapy, senior, surgery, rehabilitation, wellness, and wound care services. The firm provides cancer programs, heart and vascular center, and ambulatory surgery center services. The company was founded in 1852 and is headquartered in New Orleans, LA. | 30 Jahre |
Clint Hailey | M | - | 18 Jahre | |
Lampkin Butts | M | 72 |
Federal Reserve Bank of Atlanta
| 9 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Cam Garner | M | 75 |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | 10 Jahre |
Hazel Aker | F | 68 | 7 Jahre | |
William LaRue | M | 73 | 8 Jahre | |
Michael Chang | M | 73 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 15 Jahre |
Jeffrey C. Barbakow | M | - | 10 Jahre | |
Jack Bovender | M | 79 |
HCA, Inc.
HCA, Inc. Hospital/Nursing ManagementHealth Services HCA, Inc. engages in the provision of healthcare services. The firm specializes in general surgery, cardiology, oncology, neurology, orthopedics, and obstetrics services. The company was founded by Thomas Frist, Sr., Jack Massey, and Thomas Frist, Jr. in 1968 and is headquartered in Nashville, TN. | 12 Jahre |
Pedro Lichtinger | M | 70 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 3 Jahre |
Kurt M. Hartman | M | 51 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 3 Jahre |
Theodore Schroeder | M | 69 | 10 Jahre | |
Ronald Rittenmeyer | M | 76 | 12 Jahre | |
Alan Frazier | M | 72 | 8 Jahre | |
Michael L. Eagle | M | 76 | 6 Jahre | |
Michael Jackson | M | 75 |
Federal Reserve Bank of Atlanta
| 7 Jahre |
Russell C. Hirsch | M | 62 | 10 Jahre | |
Kathleen A. Schaefer | F | - | - | |
Bruce J. Barclay | M | 66 | 4 Jahre | |
Edward Kangas | M | 79 | 16 Jahre | |
Michael A. Berman | M | 73 | 7 Jahre | |
Christopher Lowe | M | 56 | 2 Jahre | |
James Burke | M | 55 |
Tulane University (Louisiana)
| 6 Jahre |
Douglas A. Duchak | M | - |
Rutgers State University of New Jersey
| 5 Jahre |
Paul Browne | M | 60 | - | |
Helen M. Galt | F | 76 |
Rutgers State University of New Jersey
| 5 Jahre |
Mark Auerbach | M | 85 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 8 Jahre |
Daniel Cancelmi | M | 61 | 24 Jahre | |
Samuel Barker | M | 81 | 8 Jahre | |
Michael T. MacKinnon | M | 52 | 1 Jahre | |
Alisa Norris | F | 54 |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | - |
John E. Einwalter | M | 55 | - | |
Elizabeth Smith | F | 60 |
Federal Reserve Bank of Atlanta
| - |
Thomas J. Cafferty | M | - |
Rutgers State University of New Jersey
| 7 Jahre |
Cary Vance | M | 58 | 2 Jahre | |
Vincent A. Cino | M | - |
Rutgers State University of New Jersey
| 10 Jahre |
Carrie Mendivil | F | - | - | |
John Bush | M | 70 | 7 Jahre | |
Brenda J. Gaines | F | 74 | 14 Jahre | |
Todd W. Rich | M | 68 | 6 Jahre | |
Brian Atwood | M | 71 | 8 Jahre | |
Will K. Weinstein | M | - | 1 Jahre | |
Joseph Chang | M | 71 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 15 Jahre |
E. Peter Urbanowicz | M | 60 | 5 Jahre | |
Christopher Twomey | M | 64 | 8 Jahre | |
Richard R. Pettingill | M | 76 | - | |
Allan Harvey Cohen | M | 73 |
Rutgers State University of New Jersey
| 5 Jahre |
Robert A. Waterman | M | 70 |
HCA, Inc.
HCA, Inc. Hospital/Nursing ManagementHealth Services HCA, Inc. engages in the provision of healthcare services. The firm specializes in general surgery, cardiology, oncology, neurology, orthopedics, and obstetrics services. The company was founded by Thomas Frist, Sr., Jack Massey, and Thomas Frist, Jr. in 1968 and is headquartered in Nashville, TN. | - |
James Blair | M | 84 | 9 Jahre | |
David L. Dennis | M | 75 | 2 Jahre | |
Alan R. Yuspeh | M | 74 |
HCA, Inc.
HCA, Inc. Hospital/Nursing ManagementHealth Services HCA, Inc. engages in the provision of healthcare services. The firm specializes in general surgery, cardiology, oncology, neurology, orthopedics, and obstetrics services. The company was founded by Thomas Frist, Sr., Jack Massey, and Thomas Frist, Jr. in 1968 and is headquartered in Nashville, TN. | - |
Jim M. Shapiro | M | 65 | 8 Jahre | |
Peter E. Grebow | M | 77 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 4 Jahre |
Joseph Kerrey | M | 80 | 11 Jahre | |
Karen M. Garrison | F | 75 | 13 Jahre | |
Jim A. Unruh | M | 83 | 13 Jahre | |
Carol Tomé | F | 67 |
Federal Reserve Bank of Atlanta
| 5 Jahre |
Robert Zerbe | M | 73 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 4 Jahre |
Richard Lynn Scott | M | - |
HCA, Inc.
HCA, Inc. Hospital/Nursing ManagementHealth Services HCA, Inc. engages in the provision of healthcare services. The firm specializes in general surgery, cardiology, oncology, neurology, orthopedics, and obstetrics services. The company was founded by Thomas Frist, Sr., Jack Massey, and Thomas Frist, Jr. in 1968 and is headquartered in Nashville, TN. | 4 Jahre |
Jack Schuler | M | 83 | 3 Jahre | |
Anthony Altig | M | 68 |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | 6 Jahre |
Carlos Rodriguez | M | - |
Tulane University (Louisiana)
| 5 Jahre |
Andy Heller | M | - |
Tulane University (Louisiana)
| 2 Jahre |
Anindya Chatterjee | M | - |
Tulane University (Louisiana)
| 2 Jahre |
Barry M. Miller | M | - |
Tulane University (Louisiana)
| 4 Jahre |
Harold Friedman | M | - |
Tulane University (Louisiana)
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 94 | 94,00% |
Frankreich | 6 | 6,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Stephen L. Newman
- Persönliches Netzwerk